8-144516069-CCT-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001413020.1(RECQL4):c.954-2_954-1delAG variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,612,658 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
RECQL4
NM_001413020.1 splice_acceptor, intron
NM_001413020.1 splice_acceptor, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.26
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144516069-CCT-C is Pathogenic according to our data. Variant chr8-144516069-CCT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 197759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144516069-CCT-C is described in Lovd as [Pathogenic]. Variant chr8-144516069-CCT-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1048_1049delAG | p.Arg350fs | frameshift_variant | 5/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.-24_-23delAG | 5_prime_UTR_variant | 4/20 | 1 | ENSP00000483145.1 | ||||
RECQL4 | ENST00000524998.1 | c.568_569delAG | p.Arg190fs | frameshift_variant | 3/4 | 3 | ENSP00000476579.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152216Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
18
AN:
152216
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000766 AC: 19AN: 247960Hom.: 0 AF XY: 0.0000815 AC XY: 11AN XY: 135008
GnomAD3 exomes
AF:
AC:
19
AN:
247960
Hom.:
AF XY:
AC XY:
11
AN XY:
135008
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000123 AC: 180AN: 1460442Hom.: 0 AF XY: 0.000118 AC XY: 86AN XY: 726506
GnomAD4 exome
AF:
AC:
180
AN:
1460442
Hom.:
AF XY:
AC XY:
86
AN XY:
726506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152216Hom.: 0 Cov.: 34 AF XY: 0.000134 AC XY: 10AN XY: 74368
GnomAD4 genome
AF:
AC:
18
AN:
152216
Hom.:
Cov.:
34
AF XY:
AC XY:
10
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 03, 2014 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | RECQL4: PVS1, PM2, PM3 - |
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 29, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28492532, 32769558, 25120469, 12734318, 28039508, 18716613, 21143835, 18504617, 27247962, 29642415, 29625052, 34426522, 31589614, 33718801, 34964962) - |
Rothmund-Thomson syndrome type 2 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Sep 21, 2022 | The RECQL4 c.1048_1049del (p.Arg350GlyfsTer21) change removes two nucleotides to cause a frameshift and the creation of a premature stop codon. This change is predicted to cause protein truncation or absence of the protein due to nonsense mediated decay. This variant has a maximum subpopulation frequency of 0.021% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). This variant has been reported in the literature as compound heterozygous in individuals with Rothmund–Thomson syndrome (PMID: 18716613, 21143835, 25120469, 28039508). In summary, this variant meets criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PVS1+PM3_VeryStrong+PP1_Moderate - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Jul 15, 2021 | PVS1, PM2 - |
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 07, 2022 | - - |
RECQL4-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 12, 2024 | The RECQL4 c.1048_1049delAG variant is predicted to result in a frameshift and premature protein termination (p.Arg350Glyfs*21). This variant has been reported in the compound heterozygous state in individuals with Rothmund Thomson Syndrome (RTS) (Reported as g.1798delAG, Wang et al 2003. PubMed ID: 12734318; Siitonen et al. 2008. PubMed ID: 18716613; De Somer et al. 2010. PubMed ID: 21143835; Guerrero-González et al. 2014. PubMed ID: 25120469; van Rij MC et al 2016. PubMed ID: 28039508). This variant is reported in 0.021% of alleles in individuals of African descent in gnomAD. Frameshift variants in RECQL4 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Baller-Gerold syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | This sequence change creates a premature translational stop signal (p.Arg350Glyfs*21) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs746636748, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Rothmund-Thomson syndrome (PMID: 12734318, 18716613, 21143835, 25120469, 28039508). This variant is also known as g.1798delAG. ClinVar contains an entry for this variant (Variation ID: 197759). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at